Skip to main content
Caplight Logo









Dosentrx

Dosentrx

Private
Tel AvivHealthcare & Life Scienceshttps://www.dosentrx.com/

Last Round

Seed Round

Mar 19, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Dosentrx is a healthtech company that developed ReX, a therapy management platform and smart pill-dispensing device intended to improve medication adherence for specialty treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

medication managementmedication adherencesmart pill dispenserdigital healthremote patient monitoringRPMspecialty pharmacyconnected medical devicehealth IoTpatient engagementmedication compliancemedtechvertical SaaSoncology supportcare management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dosentrx Comparables

Compare Dosentrx with similar companies based on industry and business-model similarity.

Dosentrx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spencer Health Solutions
84%
Vaica Medical
81%
Optimize Health
77%

Dosentrx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 19, 2026
GrantFeb 10, 2020
AcceleratorJun 4, 2019

Key People

Founding team and executive leadership

Alan Paz

Chief Technical Officer, Co-Founder

Founding Team

Ilan Paz

CTO

Executive Team

Liron Levi-Gabay 🇮🇱

Fractional CFO GC

Executive Team

Dosentrx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    $1.78M seed round completed.

Dosentrx Filings

Explore SEC and related filing metadata, where available.

Dosentrx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dosentrx's valuation, stock price, and market status.

Is Dosentrx a public or private company?

Dosentrx is a private company.

What is the current stock price of Dosentrx?

Dosentrx is a private company with no public stock price. No recent secondary market data is available.

How much is Dosentrx worth (valuation)?

Valuation information for Dosentrx is not publicly available.

Can I buy Dosentrx stock?

Dosentrx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dosentrx's last funding round?

Dosentrx's most recent funding round was Seed Round on March 19, 2026.

Who are the main investors in Dosentrx?

Key investors in Dosentrx include Israel National Digital Agency, Israel Innovation Authority, Startup Warrior, Ocho Capital, Texas Medical Center.

Will Dosentrx IPO soon?

No public IPO plans have been announced for Dosentrx.

How can I track Dosentrx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dosentrx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range37
Year Founded2011
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?